Biodesix Net Income 2020-2024 | BDSX
Biodesix net income from 2020 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Biodesix Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-52 |
| 2022 | $-65 |
| 2021 | $-43 |
| 2020 | $-31 |
| 2019 | $-31 |
| Biodesix Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-14 |
| 2023-12-31 | $-9 |
| 2023-09-30 | $-11 |
| 2023-06-30 | $-13 |
| 2023-03-31 | $-19 |
| 2022-12-31 | $-20 |
| 2022-09-30 | $-14 |
| 2022-06-30 | $-16 |
| 2022-03-31 | $-16 |
| 2021-12-31 | $-13 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $-11 |
| 2021-03-31 | $-7 |
| 2020-12-31 | $-5 |
| 2020-09-30 | $-9 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-10 |
| 2019-12-31 | |
| 2019-09-30 | $-10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.180B | $0.049B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.882B | 15.80 |
| Cencora (COR) | United States | $44.079B | 17.18 |
| ICON (ICLR) | Ireland | $26.293B | 24.82 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Avantor (AVTR) | United States | $16.934B | 24.93 |
| CochLear (CHEOY) | Australia | $14.061B | 0.00 |
| Revvity (RVTY) | United States | $13.822B | 24.25 |
| Viatris (VTRS) | United States | $13.181B | 3.94 |
| Natera (NTRA) | United States | $13.055B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.308B | 40.49 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.722B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.490B | 22.00 |
| Solventum (SOLV) | United States | $10.713B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| HealthEquity (HQY) | United States | $6.909B | 50.90 |
| Organon (OGN) | United States | $5.599B | 5.31 |
| Doximity (DOCS) | United States | $5.403B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $5.101B | 20.44 |
| PACS (PACS) | United States | $4.287B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.237B | 29.62 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Life Times (LTH) | United States | $3.042B | 31.88 |
| GoodRx Holdings (GDRX) | United States | $2.675B | 101.86 |
| Progyny (PGNY) | United States | $2.666B | 45.90 |
| NovoCure (NVCR) | Jersey | $2.588B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.265B | 8.98 |
| Agilon Health (AGL) | United States | $2.204B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.086B | 0.00 |
| Premier (PINC) | United States | $2.048B | 8.76 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.486B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.380B | 0.00 |
| CareDx (CDNA) | United States | $0.814B | 0.00 |
| Embecta (EMBC) | United States | $0.803B | 5.46 |
| Pediatrix Medical (MD) | United States | $0.628B | 6.66 |
| Auna S.A (AUNA) | Luxembourg | $0.623B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.612B | 16.01 |
| InnovAge Holding (INNV) | United States | $0.586B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.568B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.541B | 0.00 |
| Enhabit (EHAB) | United States | $0.449B | 44.75 |
| Sonida Senior Living (SNDA) | United States | $0.433B | 0.00 |
| ModivCare (MODV) | United States | $0.392B | 7.34 |
| MultiPlan (MPLN) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.334B | 0.00 |
| Beauty Health (SKIN) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.309B | 16.89 |
| Sharecare (SHCR) | United States | $0.303B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.268B | 0.00 |
| So-Young (SY) | China | $0.114B | 38.17 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.56 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.045B | 0.00 |
| Nutex Health (NUTX) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| DermTech (DMTK) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |